<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药明康德 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-24T11:32:04+08:00</updated>
  <subtitle>全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台，帮助任何人、任何公司更快、更好地研发新医药产品，探索无限可能</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>关注！TCR疗法喜迎首个积极3期结果，显著提高总生存率</title>
    <updated>2020-11-24T07:54:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/gYkKpa6W7Yp193uL9HB1zA</id>
    <link href="https://mp.weixin.qq.com/s/gYkKpa6W7Yp193uL9HB1zA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 默沙东拟收购昂科免疫，囊获新冠创新疗法</title>
    <updated>2020-11-24T07:54:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/J1CTtmziFtZreiSMm4xcYQ</id>
    <link href="https://mp.weixin.qq.com/s/J1CTtmziFtZreiSMm4xcYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 阿斯利康新冠疫苗达到主要功效终点，可在正常冷藏环境储存半年</title>
    <updated>2020-11-24T07:54:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/8hNLVD5OzdBBkCAw1SNfTg</id>
    <link href="https://mp.weixin.qq.com/s/8hNLVD5OzdBBkCAw1SNfTg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>十三款1类新药获批临床，来自信达生物、荣昌生物、百济神州等公司|CDE周报</title>
    <updated>2020-11-24T07:54:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/gJh9soYTu2OgcebA32noFQ</id>
    <link href="https://mp.weixin.qq.com/s/gJh9soYTu2OgcebA32noFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《科学》：强效抗体组合抑制新冠病毒，动物实验显示保护效果</title>
    <updated>2020-11-24T07:54:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/DWF3joqML5wumEm4fwox-g</id>
    <link href="https://mp.weixin.qq.com/s/DWF3joqML5wumEm4fwox-g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>26名生物医药未来之星，他们正在开辟哪些道路？</title>
    <updated>2020-11-23T07:31:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/Q20QyJP_jrEnZeeStrzWgQ</id>
    <link href="https://mp.weixin.qq.com/s/Q20QyJP_jrEnZeeStrzWgQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MIT年度“50家聪明公司”揭晓，百济神州、信达生物、复星医药、天境生物等公司上榜！</title>
    <updated>2020-11-23T07:31:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/ycvnhNOCg3s9MYPXNyKqHg</id>
    <link href="https://mp.weixin.qq.com/s/ycvnhNOCg3s9MYPXNyKqHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>多款新冠mRNA疫苗迎重要进展；FDA批准首个早衰症疗法</title>
    <updated>2020-11-23T07:31:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/GOHafWlcqD8LugMBGNGZlA</id>
    <link href="https://mp.weixin.qq.com/s/GOHafWlcqD8LugMBGNGZlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>孤儿药周报 | 三款创新抗体偶联药物，罕见肌无力基因疗法入围</title>
    <updated>2020-11-23T07:31:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/JL8uVJt4qgXidHGuTLq5cQ</id>
    <link href="https://mp.weixin.qq.com/s/JL8uVJt4qgXidHGuTLq5cQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>明日下午3点！医疗器械局部组织反应的生物相容性试验</title>
    <updated>2020-11-23T07:31:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/0PlcfGKh6kH2vzLW2TTDbA</id>
    <link href="https://mp.weixin.qq.com/s/0PlcfGKh6kH2vzLW2TTDbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞/BioNTech递交新冠疫苗EUA申请，然后呢？</title>
    <updated>2020-11-21T08:10:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/hTKYVVSPehlO4XWgPnUEww</id>
    <link href="https://mp.weixin.qq.com/s/hTKYVVSPehlO4XWgPnUEww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 获优先审评资格，首款靶向CD19的ADC有望问世</title>
    <updated>2020-11-21T08:10:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/SmRFcZAWk9sYgdOZ9kbfeg</id>
    <link href="https://mp.weixin.qq.com/s/SmRFcZAWk9sYgdOZ9kbfeg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | FDA今日批准首个早衰症疗法</title>
    <updated>2020-11-21T08:10:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/gBcaddvEH0By3NHGPalkvQ</id>
    <link href="https://mp.weixin.qq.com/s/gBcaddvEH0By3NHGPalkvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>罕见病专栏 | 一周罕闻药事（11.14-11.20）</title>
    <updated>2020-11-21T08:10:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/R0j6giPzetdzJNeG-Xqk8A</id>
    <link href="https://mp.weixin.qq.com/s/R0j6giPzetdzJNeG-Xqk8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《细胞》：传播性变强之外，新冠D614G突变毒株的致病性有什么变化</title>
    <updated>2020-11-21T08:10:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/hnKb4Nc_xRe_BBoM0ADDjg</id>
    <link href="https://mp.weixin.qq.com/s/hnKb4Nc_xRe_BBoM0ADDjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康疫苗可保护老年群体；十年老药有望治疗重症新冠患者</title>
    <updated>2020-11-20T07:53:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/2eneeRlLFugglIiWuO4u1A</id>
    <link href="https://mp.weixin.qq.com/s/2eneeRlLFugglIiWuO4u1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 第三款RNAi药物今日获欧盟批准</title>
    <updated>2020-11-20T07:53:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/zlPi9-RNC3WhU-GN5KlBsA</id>
    <link href="https://mp.weixin.qq.com/s/zlPi9-RNC3WhU-GN5KlBsA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>跳过体外环节，在患者体内直接改造T细胞，细胞疗法新锐公司完成A轮融资！</title>
    <updated>2020-11-20T07:53:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/3yiXS19tAYj1H704JymLSA</id>
    <link href="https://mp.weixin.qq.com/s/3yiXS19tAYj1H704JymLSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NEJM：优于NSCLC一线标准治疗，三代ALK抑制剂降低疾病进展或死亡风险72%</title>
    <updated>2020-11-20T07:53:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/SShAVdeka-SwS6ZEDuuc7A</id>
    <link href="https://mp.weixin.qq.com/s/SShAVdeka-SwS6ZEDuuc7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明生基扩建美国费城细胞及基因疗法生产基地， 提升高端测试服务规模 | Bilingual News</title>
    <updated>2020-11-19T07:40:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/5KljX6kuCOkdpK27VrjPtA</id>
    <link href="https://mp.weixin.qq.com/s/5KljX6kuCOkdpK27VrjPtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>